Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Cramer-Krasselt said it has won ad chores on the Zicam cold remedy following a review.
“We are very excited to start working with Cramer-Krasselt for all our creative and strategic needs,” said Bill Hemelt, president and CEO of Zicam parent Matrixx Initiatives, in a statement. “With C-K/Phoenix, we get the advantages of a large advertising network as well as the attention that a smart, talented local firm can offer.” Matrixx is based in Arizona.
The brand spent about $25 million in 2008 on ads and $15 million through November 2009, per Nielsen, but the agency said Zicam’s media outlay is expected to increase substantially — and perhaps hit $50 million — this year.
This marks C-K’s second noteworthy win of late, following its addition
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in